Oct 19, 2022, 15:56 by

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

Oct 19, 2022, 15:56 by

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Oct 19, 2022, 15:55 by

Oct 19, 2022, 09:19 by

Oct 19, 2022, 09:16 by

Oct 18, 2022, 01:00 by User Not Found

Clinical Research News | Digitalization and the changing regulatory landscape, shared space between routine clinical care and research, the increased complexity of clinical trials in decentralized settings, and practical challenges in providing patient-centric solutions were the focal points of a plenary keynote panel discussion at the recent Summit for Clinical Ops Executives Europe (SCOPE Europe) in Barcelona, Spain.

Oct 14, 2022, 10:06 by

Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement.

Oct 13, 2022, 09:49 by

Oct 13, 2022, 01:00 by User Not Found

Clinical Research News | Experts recently gathered at a bioethics symposium on ethical considerations in research for pediatric populations, hosted by the New York Academy of Sciences, for a panel discussion focused on parental permission and children capable of assenting to participation.

Oct 12, 2022, 09:37 by

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.

Oct 12, 2022, 09:36 by

Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.

Oct 12, 2022, 09:35 by

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.

Oct 12, 2022, 09:33 by

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials Risk-Based Quality Management: A front row seat to a decade of transformation

Oct 12, 2022, 01:00 by User Not Found

Clinical Research News | When it comes to balancing the need for high-quality data collection and patient-centric strategies for engaging study participants, hybrid clinical trials utilizing wearable devices and other digital health tools can be challenging to conduct. But when carefully crafted, a digital strategy can also help accelerate trials, improve diversity in recruitment, and improve outcomes for participants.

Oct 11, 2022, 11:30 by

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.

Oct 11, 2022, 11:30 by

BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.

Oct 11, 2022, 11:29 by

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.

Oct 11, 2022, 11:27 by

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

Oct 11, 2022, 11:22 by

Oct 11, 2022, 11:17 by